NCT05639608

Brief Summary

Gingivitis is a highly prevalent chronic bacterial disease in susceptible children, adults and the elderly, persisting for decades in subjects, and is an essential precursor of periodontitis. Several studies have shown periodontitis and subgingival P. gingivalis to be associated with increased C-reactive protein (CRP) levels and CRP has been implicated as a possible mediator of the association between periodontitis and several systemic diseases Limited data are available today addressing detrimental systemic effects of experimental or natural gingivitis as they have been rarely investigated. Results of various studies support the concept that gingivitis leads to systemic inflammation and that the level of systemic inflammatory markers increases proportionately with increase in gingival inflammation. It has also been seen that appropriate dental prophylaxis can also limit systemic markers of inflammation in subjects with natural gingivitis. Sex hormones have long been considered to play an influential role on periodontal tissues, bone turnover rate, wound healing and periodontal disease progression and can influence the cellular proliferation, differentiation and growth of keratinocytes and fibroblasts. Estrogen is mainly responsible for alterations in blood vessels and progesterone stimulates the production of inflammatory mediators. In addition, some micro-organisms found in the human mouth synthesize enzymes needed for steroid synthesis and catabolism. Sex hormones are neither necessary nor sufficient to produce gingival changes by themselves. However, they may alter periodontal tissue responses to microbial plaque and thus indirectly contribute to periodontal disease. (Markou). Till date, no study has been conducted assessing the serum hsCRP levels in females of reproductive age group with gingivitis. This study, thus, aims to assess the effect of scaling on serum hsCRP levels and periodontal parameters in systemically healthy women of reproductive age group with gingivitis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 26, 2022

Completed
5 days until next milestone

Study Start

First participant enrolled

December 1, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 6, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2023

Completed
Last Updated

December 6, 2022

Status Verified

November 1, 2022

Enrollment Period

8 months

First QC Date

November 26, 2022

Last Update Submit

November 26, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • bleeding on probing

    bleeding on probing will be measured on 6 sites per tooth in all the teeth

    6 months

  • gingival index

    gingival index will be measured on 4 sites per tooth in all the teeth

    6 months

  • plaque index

    plaque index will be measured on 4 sites per tooth in all the teeth

    6 months

  • serum high sensitivity c reactive protein

    serum high sensitivity C reactive protein will be measured at baseline and at 6 months

    6 months

Study Arms (2)

systemically healthy females with gingivitis

EXPERIMENTAL

scaling will be done at baseline

Procedure: SCALING

systemically and periodontally healthy females

NO INTERVENTION

data will be recorded at baseline and no intervention will be done

Interventions

SCALINGPROCEDURE

SCALING WILL BE DONE AT BASELINE IN TEST GROUP.

systemically healthy females with gingivitis

Eligibility Criteria

Age15 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsfemales of reproductive age group shall be recruited
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • females of reproductive age group (18-40 yrs)
  • BMI (18.5 - 24.9)
  • presence of ≥20 natural teeth
  • Healthy periodontium (for control group) defined as bleeding on probing at \< 10% of sites, with pockets ≤3 mm, no probing attachment loss and no radiologic bone loss.
  • Gingivitis (17) (for test group) Gingivitis (intact periodontium) is defined as bleeding on probing at ≥ 10% of sites, with pockets ≤3 mm, no probing attachment loss and no radiologic bone loss.
  • Gingivitis (reduced periodontium) is defined as bleeding on probing at ≥ 10% of sites with pockets ≤3 mm with possible probing attachment loss and possible radiologic bone loss.
  • Localized gingivitis is defined as 10-30% of bleeding sites. Generalized gingivitis is defined as more than 30% of bleeding sites.

You may not qualify if:

  • history of androgen-secreting tumors, congenital adrenal hyperplasia and thyroid dysfunction
  • nephrotic syndrome, chronic renal failure, significant cardiovascular disease, established type 1 or type 2 diabetes mellitus, active cancer within the last past 5 years
  • smokers and alcoholics
  • history of systemic antibiotics or oral contraceptives usage within last 3 months
  • periapical pathology or oral inflammatory conditions other than gingivitis.
  • any periodontal treatment within 6 months prior to study Patients with pockets ≥ 3 mm and probing attachment loss shall be excluded, hence, radiographic examination will not be needed.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Post Graduate Institute of Dental Sciences

Rohtak, Haryana, 124001, India

Location

Shikha Tewari

Rohtak, Haryana, 124001, India

Location

MeSH Terms

Conditions

Gingivitis

Interventions

Tooth Exfoliation

Condition Hierarchy (Ancestors)

InfectionsGingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Dental Physiological PhenomenaDigestive System and Oral Physiological Phenomena

Study Officials

  • Richa Verma, BDS

    Post Graduate Institute of Dental Sciences

    PRINCIPAL INVESTIGATOR

Central Study Contacts

shikha tewari, MDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 26, 2022

First Posted

December 6, 2022

Study Start

December 1, 2022

Primary Completion

July 31, 2023

Study Completion

July 31, 2023

Last Updated

December 6, 2022

Record last verified: 2022-11

Locations